Rigel Pharma 3rd-period loss widens on clinical costs
Marketwatch
Mon, 11/3/08 - 09:09 am
Vertex Is Focus at Hepatitis C Meeting
The Street.com
Mon, 11/3/08 - 09:06 am
Where Have All The Biotech IPOs Gone?
Pharmalot
Mon, 11/3/08 - 09:05 am
Four New Pharmaceutical Chief Executives Speak Out
Businessweek
Mon, 11/3/08 - 09:04 am
Study Could Widen Market For Cholesterol Treatments
WSJ Online
Mon, 11/3/08 - 09:03 am
Teva Pharmaceutical Third-Quarter Net May Rise 15%: Week Ahead
Blooomberg
Mon, 11/3/08 - 09:02 am
New Clinical Data Support Broad Profile for Telaprevir in Patients with Genotype 1 Hepatitis C Virus (HCV) Infection
Earth Times
Sat, 11/1/08 - 12:09 pm
Tibotec Presents Interim Findings for TMC435, an Investigational Genotype 1 Hepatitis C Treatment, at the AASLD Liver Meeting 2008
MarketWatch
Sat, 11/1/08 - 12:07 pm
Anadys Pharmaceuticals Announces Single Dose Safety and Pharmacokinetics Results for ANA598 in Healthy Volunteers
Street Insider
Sat, 11/1/08 - 12:04 pm
AstraZeneca Pressured by Generics
Trading Markets
Sat, 11/1/08 - 12:03 pm
Acomplia's EU suspension dispels illusion of blockbuster future
PipeLine Review
Sat, 11/1/08 - 12:02 pm
Actavis signs distribution agreement with J&M Pharma Co. Ltd in South Korea
PR-Canada.net
Sat, 11/1/08 - 12:02 pm
Anadys Pharmaceuticals Announces Single Dose Safety and Pharmacokinetics Results for ANA598 in Healthy Volunteers
MarketWatch
Sat, 11/1/08 - 12:01 pm
FDA approves drug distributed by Pfizer
TheDay, CT
Sat, 11/1/08 - 12:00 pm
Zydus drags Teva to court
Merinews, India
Sat, 11/1/08 - 11:56 am
Less Is More For Sanofi
Forbes.com
Sat, 11/1/08 - 11:54 am
Spectrum Pharmaceuticals files sNDA for Fusilev in colorectal cancer
Pharmaceutical Business Review
Sat, 11/1/08 - 11:53 am
Daiichi Sankyo to dissolve subsidiaries with Sanofi-Aventis
Pharmaceutical Business Review
Sat, 11/1/08 - 11:29 am
APRISO(TM) Granted FDA Marketing Approval for Maintenance of Remission of Ulcerative Colitis
Red Orbit
Sat, 11/1/08 - 11:26 am
Cephalon Receives FDA Approval for TREANDA to Treat Patients with Relapsed Indolent Non-Hodgkin's Lymphoma
PR NewsWire
Sat, 11/1/08 - 11:23 am

Pages